Effect of remote ischemic post-conditioning on systemic inflammatory response and survival rate in lipopolysaccharide-induced systemic inflammation model

Journal of Inflammation (United Kingdom)

Volumn 11, Issue 1, 2014, Pages

  Kim, Yun Hee ^a   Yoon, Dae Wui ^a   Kim, Je Hyeong ^a   Lee, Jeoung Hyuk ^b   Lim, Choon Hak ^a  

^a Korea University College of Medicine   (South Korea)

^b Dongguk University Ilsan Hospital   (South Korea)

Author keywords

Remote ischemic postconditioning; Remote ischemic preconditioning; Systemic inflammation

Indexed keywords

HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME ACTIVATION; ENZYME MECHANISM; EXPERIMENTAL INFLAMMATION; IMMUNOSUPPRESSIVE TREATMENT; LIPOPOLYSACCHARIDE INDUCED SYSTEMIC INFLAMMATION; LIPOPOLYSACCHARIDE-INDUCED SEPSIS; LIVER; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; SURVIVAL RATE;

EID: 84988530619     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-11-16     Document Type: Article

References (37)

1. Wenzel RP: Treating sepsis. N Engl J Med 2002, 347:966-967.
2. Dhainaut JF, Marin N, Mignon A, Vinsonneau C: Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 2001, 29:S42-S47.
3. Matuschak GM, Rinaldo JE: Organ interactions in the adult respiratory distress syndrome during sepsis. Role of the liver in host defense. Chest 1988, 94:400-406.
4. Browder W, Ha T, Chuanfu L, Kalbfleisch JH Jr, Ferguson DA, Williams DL: Early activation of pulmonary nuclear factor kappaB and nuclear factor kappaB and nuclear factor interleukin-6 in polymicrobial sepsis. J Trauma 1999, 46:590-596.
5. Yoshidome H, Kato A, Edwards MJ, Lentsch AB: Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology 1999, 30:203-208.
6. Gibbs PE, Maines MD: Biliverdin inhibits activation of NF-kappaB. reversal of inhibition by human biliverdin reductase. Int J Cancer 2007, 121:2567-2574.
7. Bellezza I, Tucci A, Galli F, Grottelli S, Mierla AL, Pilolli F, Minelli A: Inhibition of NF-κB nuclear translocation via HO-1 activation underlies α-tocopheryl succinate toxicity. J Nutr Biochem 2012, 23:1583-1591.
8. Mallick IH, Winslet MC, Seifalian AM: Ischemic preconditioning of small bowel mitigates the late phase of reperfusion injury: heme oxygenase mediates cytoprotection. Am J Surg 2010, 199:223-231.
9. Zeynalov E, Shah ZA, Li RC, Dore S: Heme oxygenase 1 is associated with ischemic preconditioning-induced protection against brain ischemia. Neurobiol Dis 2009, 35:264-269.
10. Xu B, Gao X, Xu J, Lei S, Xia ZY, Xu Y, Xia Z: Ischemic postconditioning attenuates lung reperfusion injury and reduces systemic proinflammatory cytokine release via heme oxygenase 1. J Surg Res 2011, 166:e157-e164.
11. Xia ZY, Gao J, Ancharaz AK, Liu KX, Xia Z, Luo T: Ischaemic post-conditioning protects lung from ischaemia-reperfusion injury by up-regulation of haeme oxygenase-1. Injury 2010, 41:510-516.
12. Lai IR, Chang KJ, Chen CF: The mechanism of hepatic heme oxygenase-1 expression by limb remote ischemic preconditioning. Transplantation 2007, 83:364.
13. Kanoria S, Seifalian AM, Williams R, Davidson BR: Hind limb remote preconditioning of the liver: a role for nitric oxide and HO-1. Transplantation 2007, 83:363-364.
14. Lai IR, Chang KJ, Chen CF, Tsai HW: Transient limb ischemia induces remote preconditioning in liver among rats: the protective role of heme oxygenase-1. Transplantation 2006, 81:1311-1317.
15. Tapuria N, Kumar Y, Habib MM, Abu Amara M, Seifalian AM, Davidson BR: Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury-a review. J Surg Res 2008, 150:304-330.
16. Loukogeorgakis SP, Williams R, Panagiotidou AT, Kolvekar SK, Donald A, Cole TJ, Yellon DM, Deanfield JE, MacAllister RJ: Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism. Circulation 2007, 116:1386-1395.
17. Harkin DW, Barros D'Sa AA, McCallion K, Hoper M, Campbell FC: Ischemic preconditioning before lower limb ischemia-reperfusion protects against acute lung injury. J Vasc Surg 2002, 35:1264-1273.
18. Tamion F, Richard V, Renet S, Thuillez C: Intestinal preconditioning prevents inflammatory response by modulating heme oxygenase-1 expression in endotoxic shock model. Am J Physiol Gastrointest Liver Physiol 2007, 293(6):G1308-G1314.
19. Wen T, Wu ZM, Liu Y, Tan YF, Ren F, Wu H: Upregulation of heme oxygenase-1 with hemin prevents D-galactosamine and lipopolysaccharide-induced acute hepatic injury in rats. Toxicology 2007, 237:184-193.
20. Ando H, Takamura T, Ota T, Nagai Y, Kobayashi K: Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther 2000, 294:1043-1046.
21. Yang J, Qu JM, Summah H, Zhang J, Zhu YG, Jiang HN: Protective effects of imipramine in murine endotoxin-induced acute lung injury. Eur J Pharmacol 2010, 638:128-133.
22. Zhong J, Deaciuc IV, Burikhanov R, de Villiers WJ: Lipopolysaccharide-induced liver apoptosis is increased in interleukin-10 knockout mice. Biochim Biophys Acta 2006, 1762:468-477.
23. Movat HZ, Cybulsky MI, Colditz IG, Chan MK, Dinarello CA: Acute inflammation in gram-negative infection: endotoxin, interleukin 1, tumor necrosis factor, and neutrophils. Fed Proc 1987, 46:97-104.
24. Ohzato H, Yoshizaki K, Nishimoto N, Ogata A, Tagoh H, Monden M, Gotoh M, Kishimoto T, Mori T: Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1992, 111:201-209.
25. Debets JM, Kampmeijer R, van der Linden MP, Buurman WA, van der Linden CJ: Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 1989, 17:489-494.
26. Veres B, Gallyas F Jr, Varbiro G, Berente Z, Osz E, Szekeres G, Szabo C, Sumegi B: Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol 2003, 65:1373-1382.
27. Remick DG, Newcomb DE, Bolgos GL, Call DR: Comparison of the mortality and inflammatory response of two models of sepsis : lipopolysaccharide vs. cecal ligation and puncture. Shock 2000, 13:110-116.
28. Lutz J, Thurmel K, Heemann U: Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation. J Inflamm 2010, 7:1476-9255.
29. Abraham E: Nuclear factor-kappaB and its role in sepsis-associated organ failure. J Infect Dis 2003, 15:S364-S369.
30. Roller J, Laschke MW, Scheuer C, Menger MD: Heme oxygenase (HO)-1 protects from lipopolysaccharide (LPS)-mediated liver injury by inhibition of hepatic leukocyte accumulation and improvement of microvascular perfusion. Langenbecks Arch Surg 2010, 395:387-394.
31. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, Nabel EG: Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 2001, 7:693-698.
32. Otterbein LE, Soares MP, Yamashita K, Bach FH: Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003, 24:449-455.
33. Menger MD, Rucker M, Vollmar B: Capillary dysfunction in striated muscle ischemia/reperfusion: on the mechanisms of Capillary "No-Reflow". Shock 1997, 8:2-7.
34. Wang ZH, Liang YB, Tang H, Chen ZB, Li ZY, Wu JG, Yang Q, Zeng LJ, Hu XC, Ma ZF: Expression and effects of microRNA-155 in the livers of septic mice. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2012, 24:154-157.
35. Plasenzotti R, Stoiber B, Posch M, Windberger U: Red blood cell deformability and aggregation behaviour in different animal. Clin Hemorheol Microcirc 2004, 31:105-111.
36. Morrell MR, Micek ST, Kollef MH: The management of severe sepsis and septic shock. Infect Dis Clin North Am 2009, 23:485-501.
37. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.